Protective effects of Chlorella vulgaris in lead-exposed mice infected with Listeria monocytogenes

International Immunopharmacology

Volumn 3, Issue 6, 2003, Pages 889-900

  Queiroz, Mary L S ^a   Rodrigues, Ana P O ^a   Bincoletto, Claudia ^a,b   Figueirêdo, Camila A V ^a   Malacrida, Solange ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

Chlorella vulgaris; Hematopoiesis; Interferon ; Knockout mice; Lead acetate; Listeria monocytogenes

Indexed keywords

GAMMA INTERFERON; LEAD; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CHELATION; CHLORELLA; COLONY FORMING UNIT GM; DRUG EFFECT; DRUG EFFICACY; GRANULOCYTE; HEMATOPOIESIS; IMMUNOMODULATION; LEAD BLOOD LEVEL; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTECTION; STEM CELL; THYMUS;

EID: 0038054196     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00082-1     Document Type: Article

References (60)

1. Tanaka K., Koga T., Konishi F., Nakamura M., Mitsuyama K., Nomoto K. Augmentation of host defense by a unicellular green alga, Chlorella vulgaris, to Escherichia coli infection. Infect. Immun. 53:1986;267-271.
2. Hasegawa T., Tanaka K., Ueno K., Okuda M., Yoshikai Y., Nomoto K. Augmentation of the resistance against Escherichia coli by oral administration of a hot water extract of Chlorella vulgaris in rats. Int. J. Immunopharmacol. 11:1989;971-976.
3. Hasegawa T., Yohikai Y., Okuda M., Nomoto K. Accelerated restoration of the leukocyte number and augmented resistance against Escherichia coli in cyclophosphamide-treated rats orally administered with a hot water extract of Chlorella vulgaris. Int. J. Immunopharmacol. 12:1990;883-891.
4. Hasegawa T., Okuda M., Nomoto K., Yoshikai Y. Augmentation of the resistance against Listeria monocytogenes by oral administration of a hot water extract of Chlorella vulgaris in mice. Immunopharmacol. Immunotoxicol. 16:1994;191-202.
5. Hasegawa T., Kimura Y., Hiromatsu K., Kobayashi N., Yamada A., Makino M.et al. Effect of hot water extract of Chlorella vulgaris on cytokine expression patterns in mice with murine acquired immunodeficiency syndrome after infection with Listeria monocytogenes. Immunopharmacology. 35:1997;273-282.
6. Ibusuki K., Minamishima Y. Effects of Chlorella vulgaris extract on murine cytomegalovírus infections. Nat. Immun. Cell Growth Regul. 9:1990;121-128.
7. Konishi F., Tanaka K., Kumamoto S., Hasegawa T., Okuda M., Yano I.et al. Enhanced resistance against Escherichia coli infection by subcutaneous administration of the hot-water extract of Chlorella vulgaris in cyclophosphamide-treated mice. Cancer Immunol. Immunother. 32:1990;1-7.
8. Dantas D.C.M., Queiroz M.L.S. Effects of Chlorella vulgaris on bone marrow progenitor cells of mice infected with Listeria monocytogenes. Int. J. Immunopharmacol. 21:1999;499-508.
9. Konishi F., Tanaka K., Himeno K., Taniguchi K., Nomoto K. Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to meth A tumor growth mediated by CE-induced polymorphonuclear leukocytes. Cancer Immunol. Immunother. 19:1985;73-78.
10. Morimoto T., Nagatsu A., Murakami N., Sakakibara J., Tokuda H., Nishino H.et al. Anti-tumor-promoting glyceroglycolipids from the green alga, Chlorella vulgaris. Phytochemistry. 40:1995;1433-1437.
11. Noda K., Ohno N., Tanaka K., Okuda M., Yadomae T., Nomoto K.et al. A new type of biological response modifier from Chlorella vulgaris which needs protein moiety to show an antitumour activity. Phytother. Res. 12:1998;309-319.
12. Justo G.Z., Silva M.R., Queiroz M.L.S. Effects on the green algae Chlorella vulgaris on the response of the host hematopoietic system to intraperitoneal Ehrlich ascites tumor transplantation in mice. Immunopharmacol. Immunotoxicol. 23:2001;119-132.
13. Tanaka K., Yamada A., Noda K., Shoyama Y., Kubo C., Nomoto K. Oral administration of a unicellular green algae, Chlorella vulgaris, prevents stress-induced ulcer. Planta Med. 63:1997;465-466.
14. Wilde E.W., Benemann J.R. Bioremoval of heavy metals by the use of microalgae. Biotechnol. Adv. 11:1993;781-812.
15. Veglio F., Beolchini F. Removal of metals by biosorption: a review. Hydrometallurgy. 44:1997;301-316.
16. Wong S.L., Nakamoto L., Wainwright J.F. Detection of toxic organometallic complexes in waste waters using algal assays. Arch. Environ. Contam. Toxicol. 32:1997;358-366.
17. López C.E., Castro J.M., Gonzáles V., Pérez J., Seco H.M., Fernández J.M. Determination of metal ions in algal solution samples by capillary electrophoresis. J. Chromatogr. Sci. 36:1998;352-356.
18. Lustigman B., Lee L.H., Khalil A. Effects of nickel and pH on the growth of Chlorella vulgaris. Bull. Environ. Contam. Toxicol. 55:1995;73-80.
19. Carr H.P., Cariño F.A., Yang M.S., Wong M.H. Characterization of the cadmium-binding capacity of Chlorella vulgaris. Bull. Environ. Contam. Toxicol. 60:1998;433-440.
20. Matsunaga T., Takeyama H., Nakao T., Yamazawa A. Screening of marine microalgae for bioremediation of cadmium-polluted seawater. J. Biotechnol. 70:1999;33-38.
21. Slaveykova V., Wilkinson K.J. Physicochemical aspects of lead bioaccumulation by Chlorella vulgaris. Environ. Sci. Technol. 36:2002;969-975.
22. Traviesso L., Canizares R.O., Borja R., Benitez F., Dominguez A.R., Dupeyron R.et al. Heavy metal removal by microalgae. Bull. Environ. Contam. Toxicol. 62:1999;144-151.
23. Apasheva L.M., Gusareva E.V., Kulinich A.V., Shevchenko V.A. Study of the role of thiols in determining the radiosensitivity of various strains of Chlorella vulgaris. Radiobiology. 12:1972;904-906.
24. Chappell L.T. EDTA chelation therapy should be more commonly used in the treatment of vascular disease. Altern. Ther. Health Med. 1:1995;53-57.
25. Kidd P.M. Integrative cardiac revitalization: bypass surgery, angioplasty, and chelation. Benefits, risks, and limitations. Altern. Med. Rev. 3:1998;4-17.
26. Ernest E. Chelation therapy for coronary heart disease: an overview of all clinical investigations. Am. Heart J. 140:2000;139-141.
27. Quan H., Ghali W.A., Verhoef M.J., Norris C.M., Galbraith P.D., Knudtson M.L. Use of chelation therapy after coronary angiography. Am. J. Med. 111:2001;729-730.
28. Graziano J.H., Lolacono N.J., Moulton T., Mitchell M.E., Slavkovich V., Zarate C. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. Pediatr. Pharmacol. 120:1992;133-139.
29. Flora S.J., Bhattacharya R., Vijayaraghavan R. Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fundam. Appl. Toxicol. 25:1995;233-240.
30. Klaassen C.D. Heavy metals and heavy-metal antagonists. Hardman J.G., Gilman A.G., Limbird L.E. Goodman & Gilman's the pharmacological basis of therapeutics. 1996;1649-1671 McGraw-Hill, New York.
31. Gurer H., Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic. Biol. Med. 29:2000;927-945.
32. Tandon S.K., Singh S., Jain V.K. Efficacy of combined chelation in lead intoxication. Chem. Res. Toxicol. 7:1994;585-589.
33. Quig D. Cysteine metabolism and metal toxicity. Altern. Med. Rev. 3:1998;262-270.
34. Faith R.E., Luster M.I., Kimmel C.A. Effect of chronic developmental lead exposure on cell-mediated immune functions. Clin. Exp. Immunol. 35:1979;413-420.
35. Blakley B.K., Archer D.L. Mitogen stimulation of lymphocytes exposed to lead. Toxicol. Appl. Pharmacol. 62:1982;183-189.
36. Kowolenko M., Tracy L., Lawrence D. Early effects of lead on bone marrow cell responsiveness in mice challenged with Listeria monocytogenes. Fundam. Appl. Toxicol. 17:1991;75-82.
37. Heo Y., Lee W.T., Lawrence D.A. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol. Sci. 43:1998;172-185.
38. Chen S., Golemboski K.A., Sanders F.S., Dietert R.R. Persistent effect of in utero meso-2,3-dimercaptosuccinic acid (DMSA) on immune function and lead-induced immunotoxicity. Toxicology. 132:1999;67-79.
39. McCabe M.J., Singh K.P., Reiners J.J. Lead intoxication impairs the generation of a delayed type hypersensitivity response. Toxicology. 139:1999;255-264.
40. Bincoletto C., Queiroz M.L.S. The effect of Pb on the bone marrow stem cells of mice infected with Listeria monocytogenes. Vet. Hum. Toxicol. 38:1996;186-190.
41. Van Den Heuvel R.L., Leppens H., Schoeters G.E. Lead and catechol hematotoxicity in vitro using human and murine hematopoietic progenitor cells. Cell Biol. Toxicol. 15:1999;101-110.
42. Westerman M.P., Pfitzer E., Ellis L.D., Jensen W.N. Concentrations of lead in bone in plumbism. N. Engl. J. Med. 23:1965;1246-1250.
43. Barry P.S. Letter: lead levels in blood. Nature. 258:1975;775.
44. Lawrence D.A. In vivo and in vitro effects of lead on humoral and cell-mediated immunity. Infect. Immun. 31:1981;136-143.
45. Kishikawa H., Song R., Lawrence A. Interleukin-12 promoters enhanced resistance to Listeria monocytogenes infection of Pb-exposed mice. Toxicol. Appl. Pharmacol. 147:1997;180-189.
46. Kowolenko M., Tracy L., Muzinski S., Lawrence D.A. Effects of lead on macrophage function. J. Leukoc. Biol. 43:1988;357-364.
47. Kim D., Lawrence D.A. Immunotoxic effects of inorganic lead on host resistance of mice with different circling behavior preferences. Brain Behav. Immun. 14:2000;305-317.
48. Metcalf D. The hemopoietic colony stimulating factors. 1984;Elsevier, New York.
49. Hessel D.W. A simple and rapid quantitative determination of lead in blood. At. Absorpt. Newsl., Norwalk. 7:1968;55-56.
50. Skoczynska A. Lipid peroxidation as a toxic mode of action for lead and cadmium. Med. Pr. 48:1997;197-203.
51. Parker C.W. Lipid mediators produced through the lipoxygenase pathway. Annu. Rev. Immunol. 5:1987;65-84.
52. Domínguez-Gerpe L., Rey-Méndez M. Modulation of stress-induced murine lymphoid tissue involution by age, sex and strain: role of bone marrow. Mech. Ageing Dev. 104:1998;195-205.
53. Dhabhar F.S., Miller A.H., McEwen B.S. Effects of stress on immune cell distribution. J. Immunol. 154:1995;5511-5527.
54. Hasegawa T., Noda K., Kumamoto S., Ando Y., Yamada A., Yohikai Y. Chlorella vulgaris culture supernatant (CVS) reduces psychological stress-induced apoptosis in thymocytes of mice. Int. J. Immunopharmacol. 22:2000;877-885.
55. Tian L., Lawrence D.A. Pb inhibits nitric oxide production in vitro by murine splenic macrophages. Toxicol. Appl. Pharmacol. 132:1995;156-163.
56. Heo Y., Parsons P.J., Lawrence D.A. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol. Appl. Pharmacol. 138:1996;149-157.
57. Queiroz M.L.S., Bincoletto C., Valadares M.C., Dantas D.C.M., Santos L.M.B. Effects of Chlorella vulgaris extract on cytokines production in Listeria monocytogenes infected mice. Immunopharmacol Immunotoxicol. 24(3):2002;483-496.
58. Cheers C., McKenzie F.C. Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect. Immun. 19:1978;755-765.
59. Kumamoto S., Ando Y., Yamada A., Nomoto K., Yasumobu Y. Oral administration of hot water extracts of Chlorella vulgaris reduces IgE production against milk casein in mice. Int. J. Immunopharmacol. 21:1999;311-323.
60. Skamene E., Kongshavn P.A.L. Phonotypic expression of genetically controlled host resistance to Listeria monocytogenes. Infect. Immun. 25:1979;345-351.